Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR
· Real-Time Price · USD
35.87
0.01 (0.03%)
At close: Aug 15, 2025, 3:59 PM
35.71
-0.45%
After-hours: Aug 15, 2025, 04:10 PM EDT
Monopar Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.03 | -23.95 | -19.08 | -0.00 | -1.89 | -8.28 | -3.49 | -5.6 | -6.53 | -9.71 | -13.3 | -10.1 | -13.15 | -16.36 | -18.83 | -31.16 | -44.49 | -49.93 |
PEG Ratio | 0.00 | -0.77 | 0.88 | 0.00 | -0.00 | 0.50 | 0.24 | 0.45 | 0.59 | 0.53 | -0.84 | 0.74 | -0.83 | 1.72 | -3.77 | -1.77 | -7.12 | 3.16 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.00 | 4.69 | 15.15 | 4.80 | 2.13 | 7.27 | 4.53 | 6.62 | 7.33 | 10.18 | 15.21 | 7.75 | 10.01 | 9.47 | 10.66 | 14.40 | 15.85 | 14.99 |
P/FCF Ratio | -0.04 | -44.41 | -417.25 | -22.1 | -7.75 | -32.82 | -16.39 | -22.56 | -27.33 | -40.11 | -117.85 | -45.12 | -110.83 | -65.13 | -99.39 | -157.83 | -263.27 | -194.17 |
P/OCF Ratio | -0.04 | -44.41 | -417.25 | -0.01 | -7.75 | -32.82 | -16.39 | -22.56 | -27.33 | -40.11 | -117.85 | -45.12 | -110.83 | -65.13 | -99.39 | -157.83 | -263.27 | -194.17 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | 0.00 | n/a | n/a | n/a | n/a |
Quick Ratio | 33.94 | 36.92 | 11.47 | 5.41 | 6.59 | 6.21 | 4.17 | 4.32 | 4.12 | 4.08 | 4.21 | 7.51 | 7.61 | 16.77 | 12.98 | 18.10 | 22.10 | 32.05 |
Current Ratio | 33.94 | 36.92 | 11.47 | 5.41 | 6.59 | 6.21 | 4.17 | 4.32 | 4.12 | 4.08 | 4.21 | 7.51 | 7.61 | 16.77 | 12.98 | 18.10 | 22.10 | 32.05 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.05 | -0.05 | -0.2 | -263.66 | -0.28 | -0.22 | -0.32 | -0.3 | -0.28 | -0.26 | -0.29 | -0.19 | -0.19 | -0.14 | -0.14 | -0.12 | -0.09 | -0.08 |
Return on Assets | -0.05 | -0.05 | -0.18 | -214.88 | -0.24 | -0.18 | -0.25 | -0.23 | -0.21 | -0.2 | -0.22 | -0.17 | -0.17 | -0.14 | -0.13 | -0.11 | -0.09 | -0.07 |
Return on Invested Capital | -0.06 | -0.06 | -0.2 | -0.32 | -0.29 | -0.23 | -0.34 | -0.31 | -0.3 | -0.27 | -0.29 | -0.19 | -0.19 | -0.14 | -0.14 | -0.12 | -0.09 | -0.08 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |